Frontiers Case report: Short-term eculizumab use in atypical HUS
Por um escritor misterioso
Descrição
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
PDF) Anti-factor H antibody and its role in atypical hemolytic uremic syndrome
Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies - ScienceDirect
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
PDF] Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Frontiers Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review
PDF) The use of eculizumab in gemcitabine induced thrombotic microangiopathy
PDF) Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab Dosing
de
por adulto (o preço varia de acordo com o tamanho do grupo)
